ArticleGastro hep advances2026
Digital Vaccine Initiative for Inflammatory Bowel Disease Patients Using the Consolidated Framework for Implementation Research.
Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Digital health interventions may improve preventive care for patients with inflammatory bowel disease, but implementation barriers can limit effectiveness. We evaluated a multisite digital vaccine outreach initiative and identified implementation barriers and facilitators using the Consolidated Framework for Implementation Research. Methods: We conducted a qualitative case study across 3 academic medical centers from 2022 to 2024. Survey responses from clinical coordinators and principal investigators were coded within Consolidated Framework for Implementation Research domains. The intervention used automated text messages with links to patient education and interactive health assessments. Results: Patient engagement was limited at all sites. Pre-existing vaccination programs facilitated integration, whereas sites without established infrastructure faced greater difficulty. Institutional constraints, including institutional review board restrictions that excluded two-thirds of patients at one site, limited enrollment. Many patients distrusted unsolicited automated messages and perceived embedded links as phishing attempts. Weekly staff time varied substantially, and turnover disrupted implementation continuity. Despite limited platform engagement, the initiative increased provider attention to vaccination. Conclusion: Digital vaccine initiatives require more than technology deployment. Successful implementation should include early assessment of institutional capacity, patient-centered design addressing trust and communication preferences, baseline needs assessment, structured implementation support, and clear gastroenterology-primary care workflows. Hybrid approaches combining digital outreach with communication from known clinicians or nurses may be more effective than fully automated messaging for preventive care in inflammatory bowel disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.